Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RG7386 |
Synonyms | |
Therapy Description |
RO6874813 (RG7386) is a bispecific antibody that binds TNFRSF10B (DR5) on tumor cells and fibroblast-activation protein (FAP) found on fibroblasts in the tumor stroma to induce apoptosis (PMID: 27037412). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RG7386 | RO6874813|RG 7386|RG-7386 | RO6874813 (RG7386) is a bispecific antibody that binds TNFRSF10B (DR5) on tumor cells and fibroblast-activation protein (FAP) found on fibroblasts in the tumor stroma to induce apoptosis (PMID: 27037412). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02558140 | Phase I | RG7386 | A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors | Completed | USA | FRA | ESP | 0 |